tirzepatide at night Is Better In The Morning or Night? Tirzepatide (Mounjaro) in Princeton |
Description
Tirzepatide (Mounjaro, Zepbound) produces around 20.9% body weight loss at 72 weeks in the SURMOUNT-1 trial
Wilken M
There was often a consistent decline in visceral fat, with the majority of the reduction observed at week 24
This, in turn, leads to an improved intestinal barrier, reduced circulating levels of gut-derived toxins, and a significant reduction in inflammation
Best for: People whose primary challenge is food cravings or emotional eating rather than physical hunger
